No, but every time I find a Bio tech stock that looks like they have a decent drug it fails for the craziest reasons. This one is different but to go from 40M shares and a healthy $1.47 to $0.70 in a week on good news doesn't present itself as a bright future for Reolysin. These stocks are all gamblers dreams but Reolysin is really making a difference. Would hate to think my $40K that's now 30K is in jepordy!